期刊文献+

脑胶质瘤患者术前及术后血清内皮抑素的表达情况及对比研究 被引量:3

Expression and comparative study of serum endostatin preoperative and postoperative in human glioma
下载PDF
导出
摘要 目的探讨内皮抑素(ES)在人脑胶质瘤患者术前及术后血清中的表达水平和意义。方法采用ELISA方法检测46例脑胶质瘤患者术前及术后血清中内皮抑素表达水平,同时选取10例健康人群血清标本作为正常对照。结果健康人群血清中ES平均含量为20.74±1.48 ng/ml,胶质瘤患者术前血清中ES平均含量为26.63±5.63 ng/ml,且随着胶质瘤恶性程度的增加呈升高趋势。结论胶质瘤患者术后5-6天血清中ES平均含量为20.77±3.39 ng/ml,明显低于术前水平。结论血清中内皮抑素的含量水平反映了肿瘤的生长状况,与胶质瘤的恶性程度及预后有关。 Objective To assess the expression and significance of serum endostatin preoperative and postoperative in human glioma.Methods ELISA method was used to detect the expressions of serum endostatin in 46 glioma patients preoperative and postoperative respectively.10 healthy individuals were selected as normal controls.Results The average level of endostatin in healthy individuals was 20.74±1.48 ng/ml,while in glioma patients preoperative was 26.63±5.63 ng/ml,which tended to increase with the increase of glioma pathological grade.On the other side,the average endostatin level in glioma patients postoperative was 20.77±3.39 ng/ml,which was significantly lower than preoperative level.Conclusion The levels of serum endostatin in glioma patients reflected the status of tumor growth and correlated with glioma pathogenic grade and prognosis closely.
出处 《中国实验诊断学》 北大核心 2011年第5期826-828,共3页 Chinese Journal of Laboratory Diagnosis
基金 吉林省科技发展计划项目(20070729-12)
关键词 内皮抑素 胶质瘤 血清 Endostatin glioma serum
  • 相关文献

参考文献3

二级参考文献33

  • 1刘陶文,陈煌基,常捷燕,李西融.鼻咽癌患者血清VEGF、Endostatin和TSGF水平的相互关系[J].实用癌症杂志,2005,20(1):62-64. 被引量:6
  • 2HongLiu,Ying-BinLiu,Yu-LianWu,Zhi-MingZhao,YongWang,Bao-SanHan,Cheng-HongPeng.Inhibitory effect of adeno-associated virus-mediated gene transfer of human endostatin on hepatocellular carcinoma[J].World Journal of Gastroenterology,2005,11(22):3331-3334. 被引量:11
  • 3徐爱晖,尹岩伟,陈飞虎.肺癌患者血清内皮抑素水平对肺癌早期诊断价值的研究[J].中华医学杂志,2006,86(27):1916-1918. 被引量:13
  • 4Ramanujan S, Koenig GC, Padera TP, et al. Local imbalance of proangiogenic and antiangiogenic factors:a potential mechanism of focal necrosis and dormancy in tumors. Cancer Res, 2000, 60: 1422-1428.
  • 5O'Reilly MS,Boehm T,Shing Y,et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell, 1997,88 : 277- 285.
  • 6Feldman AL, Alexander HR Jr, Bartlett DL, et al. A prospective analysis of plasma endostatin levels in colorectal cancer patients with liver metastases. Ann Surg 0ncol,2001,8:741-745.
  • 7Feldman AL, Pak H, Yang JC, et al. Serum endostatin levels are elevated in patients with soft tissue sarcoma. Cancer, 2001,91 : 1525-1529.
  • 8Guan KP, Ye HY, Yan Z, et al. Serum levels of endostatin and matrix metalloproteinase-9 associated with high stage and grade primary transitional cell carcinoma of the bladder. Urology, 2003, 61:719-723.
  • 9Dhar DK, Ono T, Yamanoi A, et al. Serum endostatin predicts tumor vascularity in hepatocellular carcinoma. Cancer, 2002,95 : 2188-2195.
  • 10Feldman AL, Alexander HR Jr, Yang JC, et al. Prospective analysis of circulating endostatin levels in patients with renal cell carcinoma. Cancer,2002,95:1637-1643.

共引文献2

同被引文献7

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部